摘要
目的探讨新生儿ABO溶血病治疗临床路径的应用价值。方法比较临床路径组(45例)和对照组(45例)新生儿ABO溶血病治疗的住院费用、住院时间、患儿家长满意度及治疗效果。结果与对照组比较,临床路径组患儿住院时间缩短、住院费用降低、患儿家长满意度增加(P<0.05)。治疗后两组患儿血清胆红素均明显下降。结论在保证医疗质量的前提下,临床路径用于新生儿ABO溶血病治疗具有住院费用低、住院时间短、患儿家长满意度高的优点。
Objective To investigate the application value of a clinical pathway in the treatment of neonatal ABO hemolytic disease.Methods The outcomes of standard clinical pathway for the management of neonatal ABO hemolytic disease were analyzed in 45 newborns（group A）,which were compared with those in 45 newborns（group C） who were managed conventionally.Results Compared with group C,the hospital stay was shorter,the hospitalization expenses were lower,and the parents′ satisfaction rate was higher in group A（P0.05）.Serum level of bilirubin was decreased after the treatment in both groups.Conclusion A clinical pathway used for the management of neonatal ABO hemolytic disease has obvious advantages of lower hospital stay and expenses,and higher parents′satisfaction rate.
出处
《江苏医药》
CAS
北大核心
2013年第14期1644-1646,共3页
Jiangsu Medical Journal
